Recombinant factor VIIa: a general hemostatic agent? Not yet

This publication has 18 references indexed in Scilit:

• Recombinant activated factor VII for the treatment of life-threatening haemorrhage
  Blood Coagulation & Fibrinolysis, 2003
• Incidence of the Major Stroke Subtypes
  Stroke, 2001
• An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII
  Anesthesia & Analgesia, 2001
• An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII
  Anesthesia & Analgesia, 2001
• The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis
  Chest, 2001
• Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
  The Lancet, 1999
• Treatment of traumatic bleeding with recombinant factor VIIa
  The Lancet, 1999
• Hemostatic Drugs
  New England Journal of Medicine, 1998
• Anti-Endotoxin Monoclonal Antibodies — A Second Look
  New England Journal of Medicine, 1992
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983